Journal of Clinical Densitometry
Volume 9, Issue 4 , Pages 388-392 , October 2006

DXA Quality Matters

  • E. Michael Lewiecki

      Affiliations

    • New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM
    • Corresponding Author InformationAddress correspondence to: E. Michael Lewiecki, MD, FACP, New Mexico Clinical Research & Osteoporosis Center, 300 Oak St. NE, Albuquerque, NM 87106.
    • ,
  • Neil Binkley

      Affiliations

    • University of Wisconsin, Madison, WI
    • ,
  • Steven M. Petak

      Affiliations

    • Texas Institute for Reproductive Medicine, Houston, TX

Received 31 May 2006 ,Accepted 10 July 2006.

References 

  1. National Osteoporosis Foundation . America's bone health: the state of osteoporosis and low bone mass in our nation. Washington, DC: National Osteoporosis Foundation; 2002;
  2. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ. Population-based study of survival after osteoporotic fractures. Am J Epidemiol. 1993;137:1001–1005
  3. Riggs BL, Melton LJ. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995;17(Suppl):505S–511S
  4. Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C. Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev. 2002;23:570–578
  5. Lewiecki EM, Binkley N, Petak S. Impact of DXA quality on patient care: clinician and technologist perceptions. J Bone Miner Res. 2006;21(Suppl 1):S354
  6. Lotz JC, Cheal EJ, Hayes WC. Fracture prediction for the proximal femur using finite element models: Part I–Linear analysis. J Biomechan Eng. 1991;113:353–360
  7. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–1259
  8. Cranney A, Tugwell P, Wells G, Guyatt G. Systematic reviews of randomized trials in osteoporosis: Introduction and methodology. Endocr Rev. 2002;23:497–507
  9. Wasnich RD, Miller PD. Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab. 2000;85:231–236
  10. Mazess R, Chesnut CH, McClung M, Genant H. Enhanced precision with dual-energy X-ray absorptiometry. Calcif Tissue Int. 1992;51:14–17
  11. Njeh CF, Fuerst T, Hans D, Blake GM, Genant HK. Radiation exposure in bone mineral density assessment. Applied Radiation & Isotopes. 1999;50:215–236
  12. Watts NB. Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA). Osteoporos Int. 2004;15:847–854
  13. US Department of Health and Human Services . Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2004;

PII: S1094-6950(06)00223-X

doi: 10.1016/j.jocd.2006.07.002

Journal of Clinical Densitometry
Volume 9, Issue 4 , Pages 388-392 , October 2006

Article Tools

* Image Usage & Resolution